Bafna Pharmaceuticals Limited's market cap is currently ₹4.14B. The company's EPS TTM is ₹1.433; its P/E ratio is 50.13; Bafna Pharmaceuticals Limited is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 23
Dec 22
Dec 21
Dec 20
Currency in INR
Bafna Pharmaceuticals Limited Earnings and Revenue History
